Introduction: A New Milestone in Veterinary Excellence

In a significant development for the global veterinary community, the North American Veterinary Community (NAVC) and the Human Animal Bond Research Institute (HABRI) jointly announced this week at the American Veterinary Medical Association (AVMA) Convention that Boehringer Ingelheim has officially been designated a Human-Animal Bond Certified Company.

This prestigious certification serves as a formal recognition of the pharmaceutical giant’s steadfast commitment to the science of the human-animal bond. By aligning with HABRI and the NAVC, Boehringer Ingelheim is signaling a strategic shift in how veterinary medicine is practiced—moving beyond clinical diagnostics to embrace the profound psychological and physiological benefits that companion animals provide to their human counterparts.


The Core Facts: What This Certification Means

The Human-Animal Bond Certification is not merely an honorary title; it is a rigorous, evidence-based program that requires deep institutional commitment. Boehringer Ingelheim’s attainment of this status highlights its dedication to:

  • Elevating Education: Supporting the dissemination of scientific research regarding the health benefits of pets.
  • Operational Integration: Implementing internal training programs to ensure that employees and representatives understand the mechanics and importance of the human-animal bond.
  • Accessibility: Providing financial and structural support to make the certification more accessible to individual veterinary professionals and clinics across North America.

For the veterinary industry, this means that one of the largest animal health companies in the world is now formally invested in the philosophy that healthier animals lead to healthier, more connected human communities.


A Chronological Perspective: Building the Bond

To understand the weight of this announcement, one must look at the evolution of the Human-Animal Bond Certification program and the organizations behind it.

The Inception (2018)

The Human-Animal Bond Certification was launched in 2018 as a collaborative effort between the NAVC and HABRI. Recognizing that veterinarians often lack formal training in the psychology of the client-patient relationship, these organizations developed a 7.5-hour, RACE-approved continuing education (CE) course. The goal was to provide clinicians with the tools to talk about the health benefits of pet ownership and to strengthen the rapport within the clinic.

The Growth Phase (2018–2023)

Since its inception, the program has steadily gained momentum. As of 2024, more than 1,280 veterinary professionals—including veterinarians, technicians, and practice managers—have earned their certification. The program has been hosted on VetFolio, the NAVC’s industry-leading digital platform, allowing for flexible, virtual learning that fits into the demanding schedules of modern practitioners.

The Current Milestone (2024)

The announcement at the AVMA Convention marks a transition from individual certifications to corporate-level adoption. Boehringer Ingelheim’s decision to become a "Human-Animal Bond Certified Company" represents the first time a major industry partner has fully integrated this certification philosophy into its corporate identity.


Supporting Data: Why the Human-Animal Bond Matters

The certification program is rooted in science. HABRI has spent years funding and curating research that proves the tangible medical benefits of the human-animal bond.

The Science of Connection

Research supported by HABRI has consistently demonstrated that the presence of companion animals can:

  • Lower Blood Pressure: Studies have shown that interacting with pets can reduce systolic and diastolic blood pressure.
  • Reduce Anxiety and Depression: The release of oxytocin, often called the "love hormone," occurs during positive interactions between humans and animals, helping to mitigate symptoms of clinical anxiety.
  • Improve Cardiovascular Health: Patients with pets often exhibit better heart-health metrics compared to those without.
  • Foster Community: Pets act as social catalysts, increasing social capital and decreasing feelings of loneliness in urban and rural settings alike.

The Clinic-Level Impact

By integrating this science into the veterinary curriculum, the certification program aims to shift the veterinary encounter from a purely transactional medical visit to a holistic care model. When veterinarians understand the depth of the bond, they are better equipped to communicate with clients, improve compliance, and ultimately provide better medical outcomes for the pets under their care.


Official Responses: Voices from the Industry

The significance of this partnership was echoed by the leadership of both the participating organizations and the corporation itself.

Fabio Paganini, President, US Commercial Business for Boehringer Ingelheim

"Achieving the status of a Human Animal Bond Certification Company is a meaningful designation for our team and our customers," said Paganini. "It demonstrates our support for the veterinary profession and our core belief that healthier animals contribute to healthier communities and stronger human connections. This is about more than just medicine; it is about acknowledging the vital role our patients play in the lives of the people who love them."

Gene O’Neill, CEO of the NAVC and Vice Chair of HABRI’s Board of Trustees

"Alongside HABRI, NAVC is proud to recognize Boehringer Ingelheim for its commitment to expanding awareness about the importance of the human-animal bond and to supporting greater access to human-animal bond education for the veterinary community," O’Neill stated. His dual role highlights the synergy between the two organizations—the NAVC provides the educational platform, while HABRI provides the scientific backbone.


The Path Forward: Implications for Veterinary Medicine

What does this mean for the future of the veterinary profession? The implications are three-fold:

1. Standardization of Care

As more companies and clinics adopt the principles of the Human-Animal Bond Certification, there will likely be a standardization of communication styles in the clinic. Clients can expect their veterinarians to not only treat the animal’s physical ailments but also to recognize and validate the emotional significance of the pet.

2. Industry-Wide Advocacy

Boehringer Ingelheim’s participation is expected to act as a catalyst. Other veterinary suppliers, diagnostic companies, and pet food manufacturers may feel compelled to follow suit, creating a "virtuous cycle" where the entire industry focuses on the holistic well-being of the human-animal dyad.

3. Strengthening the Veterinary Workforce

The veterinary profession has faced significant burnout in recent years. By focusing on the "human" side of the human-animal bond, the industry may find new ways to connect with clients, potentially reducing the emotional toll of difficult medical decisions and enhancing the overall job satisfaction of veterinary staff.


Deep Dive: The Role of the NAVC and HABRI

To appreciate the scale of this initiative, one must understand the organizations facilitating it.

The North American Veterinary Community (NAVC)

Founded in 1982, the NAVC has grown into a global powerhouse for veterinary continuing education. Headquartered in Orlando, Florida, the nonprofit manages a vast ecosystem of resources:

  • VMX (Veterinary Meeting & Expo): The largest veterinary conference in the world, serving as a hub for innovation and networking.
  • VetFolio: The digital learning engine that hosts the Human-Animal Bond Certification course.
  • Advocacy: The NAVC’s role in uniting pet owners and professionals ensures that the "human" element of the bond remains at the forefront of public policy.

The Human Animal Bond Research Institute (HABRI)

HABRI is the scientific engine of this movement. As a not-for-profit organization, its mission is to:

  • Fund innovative research that quantifies the benefits of the human-animal bond.
  • Maintain the world’s largest online library of human-animal interaction (HAI) research.
  • Serve as a bridge between the scientific community and the general public, translating complex medical findings into actionable advice for pet owners.

Conclusion: A New Era of Holistic Veterinary Care

The decision by Boehringer Ingelheim to earn Human-Animal Bond Certification is a watershed moment for the veterinary industry. It signals that the future of animal medicine is not just about pharmaceuticals and diagnostics, but about the profound, life-altering connection between species.

As the industry continues to evolve, the integration of these principles into daily practice will likely become the standard rather than the exception. With over 1,280 professionals already certified and the support of a major industry leader, the movement is poised to grow, ensuring that both people and pets live longer, healthier, and more connected lives.

For the pet owner, this means a more empathetic veterinary experience. For the veterinarian, it provides a deeper purpose for their work. And for the industry, it creates a unified front in advocating for the essential role that companion animals play in the health and happiness of our society. As we look toward the future, it is clear that the bond between human and animal is no longer just a sentiment—it is a cornerstone of professional medical practice.